Novel Blood-Based, Five-Gene Biomarker Set for the Detection of Colorectal Cancer
Open Access
- 15 January 2008
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (2), 455-460
- https://doi.org/10.1158/1078-0432.ccr-07-1801
Abstract
Purpose: We applied a unique method to identify genes expressed in whole blood that can serve as biomarkers to detect colorectal cancer (CRC). Experimental Design: Total RNA was isolated from 211 blood samples (110 non-CRC, 101 CRC). Microarray and quantitative real-time PCR were used for biomarker screening and validation, respectively. Results: From a set of 31 RNA samples (16 CRC, 15 controls), we selected 37 genes from analyzed microarray data that differed significantly between CRC samples and controls (P < 0.05). We tested these genes with a second set of 115 samples (58 CRC, 57 controls) using quantitative real-time PCR, validating 17 genes as differentially expressed. Five of these genes were selected for logistic regression analysis, of which two were the most up-regulated (CDA and MGC20553) and three were the most down-regulated (BANK1, BCNP1, and MS4A1) in CRC patients. Logit (P) of the five-gene panel had an area under the curve of 0.88 (95% confidence interval, 0.81-0.94). At a cutoff of logit (P) >+0.5 as disease (high risk), <−0.5 as control (low risk), and in between as an intermediate zone, the five-gene biomarker combination yielded a sensitivity of 94% (47 of 50) and a specificity of 77% (33 of 43). The intermediate zone contained 22 samples. We validated the predictive power of these five genes with a novel third set of 92 samples, correctly identifying 88% (30 of 34) of CRC samples and 64% (27 of 42) of non-CRC samples. The intermediate zone contained 16 samples. Conclusion: Our results indicate that the five-gene biomarker panel can be used as a novel blood-based test for CRC.Keywords
This publication has 39 references indexed in Scilit:
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression ProfilingAmerican Journal of Transplantation, 2005
- Blood-based biomarkers for detecting mild osteoarthritis in the human kneeOsteoarthritis and Cartilage, 2005
- Factors associated with colon cancer screening: the role of patient factors and physician counselingPreventive Medicine, 2005
- Delineation of the minimal commonly deleted segment and identification of candidate tumor‐suppressor genes in del(9q) acute myeloid leukemiaGenes, Chromosomes and Cancer, 2005
- Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathologyGut, 2005
- Sensitivity to Gemcitabine and Its Metabolizing Enzymes in NeuroblastomaClinical Cancer Research, 2005
- Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodThe Journal of Experimental Medicine, 2003
- Molecular cloning and characterization of the protein 4.1O gene, a novel member of the protein 4.1 family with focal expression in ovaryJournal of Human Genetics, 2003
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996